Thyroid Cancers

Also known as: Thyroid Cancer / Malignant neoplasm of thyroid gland / Thyroid neoplasms malignant / Thyroid neoplasm malignant / Thyroid gland cancer

DrugDrug NameDrug Description
DB01268SunitinibSunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib inhibits cellular signaling by targeting multiple RTKs. These include all platelet-derived growth factor receptors (PDGF-R) and vascular endothelial growth factor receptors (VEGF-R). Sunitinib also inhibits KIT (CD117), the RTK that drives the majority of GISTs. In addition, sunitinib inhibits other RTKs including RET, CSF-1R, and flt3.
DrugDrug NamePhaseStatusCount
DB00307Bexarotene0Completed1
DB11714Durvalumab0Recruiting1
DB00928Azacitidine1Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB06589Pazopanib1Active Not Recruiting1
DB09037Pembrolizumab1Recruiting1
DB08911Trametinib1Active Not Recruiting1
DB08881Vemurafenib1Completed1
DB01101Capecitabine1 / 2Terminated1
DB00851Dacarbazine1 / 2Terminated1
DB00619Imatinib1 / 2Terminated1
DB00112Bevacizumab2Unknown Status1
DB01101Capecitabine2Completed1
DB06643Denosumab2Completed1
DB05928Dovitinib2Completed1
DB00997Doxorubicin2Active Not Recruiting1
DB01590Everolimus2Active Not Recruiting2
DB01590Everolimus2Recruiting1
DB00619Imatinib2Terminated1
DB06186Ipilimumab2Recruiting1
DB11733Irofulven2Completed1
DB09078Lenvatinib2Completed2
DB09078Lenvatinib2Recruiting2
DB01356Lithium2Completed1
DB09035Nivolumab2Recruiting1
DB01229Paclitaxel2Unknown Status1
DB06663Pasireotide2Active Not Recruiting1
DB00642Pemetrexed2Unknown Status1
DB08896Regorafenib2Recruiting1
DB11836Sapanisertib2Recruiting1
DB00398Sorafenib2Active Not Recruiting1
DB00398Sorafenib2Completed1
DB00398Sorafenib2Recruiting1
DB06287Temsirolimus2Active Not Recruiting1
DB04960Tipifarnib2Recruiting1
DB05294Vandetanib2Active Not Recruiting1
DB05294Vandetanib2Completed1
DB05238Vemurafenib2Recruiting1
DB08881Vemurafenib2Recruiting1
DB05153Cabozantinib3Active Not Recruiting1
DB08875Cabozantinib3Active Not Recruiting1
DB09078Lenvatinib3Active Not Recruiting1
DB05294Vandetanib3Active Not Recruiting1
DB12217Iodide I-1314Completed1
DB00451Levothyroxine4Recruiting1
DB00024Thyrotropin Alfa4Completed1
DB05294Vandetanib4Active Not Recruiting1
DB00668EpinephrineNot AvailableCompleted1
DB09150Fludeoxyglucose F-18Not AvailableWithdrawn1
DB09420Iodide I-123Not AvailableWithdrawn1
DB00451LevothyroxineNot AvailableRecruiting1
DB00281LidocaineNot AvailableCompleted1
DB00279LiothyronineNot AvailableCompleted1
DB01378MagnesiumNot AvailableCompleted1
DB11689SelumetinibNot AvailableCompleted1
DB01268SunitinibNot AvailableCompleted1